Eur Rev Med Pharmacol Sci 2018; 22 (4): 863-865
DOI: 10.26355/eurrev_201802_14363

The challenge of clinical application of FM2 cannabis oil produced in Italy for the treatment of neuropathic pain

S. Pichini, R. Pacifici, F.P. Busardò, A. Tagliabracci, R. Giorgetti

National Centre on Addiction and Doping, Istituto Superiore di Sanita, Rome, Italy. fra.busardo@libero.it

Free PDF Download

To cite this article

S. Pichini, R. Pacifici, F.P. Busardò, A. Tagliabracci, R. Giorgetti
The challenge of clinical application of FM2 cannabis oil produced in Italy for the treatment of neuropathic pain

Eur Rev Med Pharmacol Sci
Year: 2018
Vol. 22 - N. 4
Pages: 863-865
DOI: 10.26355/eurrev_201802_14363

Keywords Related articles:

  1. Modulating cAMP responsive element binding protein 1 attenuates functional and behavioural deficits in rat model of neuropathic pain
  2. Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study
  3. Clinical application of highly agglutinative staphylococcin in cancer treatment updates of the literature
  4. Sublingual sufentanil, a new opportunity for the improvement of postoperative pain management in Italy
  5. Neuropathic pain following spinal cord injury: what we know about mechanisms, assessment and management